Michael J. Bower

2.3k total citations
18 papers, 1.5k citations indexed

About

Michael J. Bower is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael J. Bower has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Michael J. Bower's work include Protein Structure and Dynamics (3 papers), Protein Tyrosine Phosphatases (3 papers) and Melanoma and MAPK Pathways (3 papers). Michael J. Bower is often cited by papers focused on Protein Structure and Dynamics (3 papers), Protein Tyrosine Phosphatases (3 papers) and Melanoma and MAPK Pathways (3 papers). Michael J. Bower collaborates with scholars based in United States, United Kingdom and Austria. Michael J. Bower's co-authors include Roland L. Dunbrack, Fred E. Cohen, Jerry L. Adams, John C. Lee, Baoguang Zhao, Min Wei, Andrew P. Combs, Sanjay Kumar, Rebecca J. Gum and Brian Wayland and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Michael J. Bower

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Bower United States 15 1.1k 249 192 184 173 18 1.5k
Marilena Manea Germany 21 746 0.7× 64 0.3× 176 0.9× 281 1.5× 160 0.9× 50 1.4k
Shilpa Sambashivan United States 11 1.9k 1.7× 390 1.6× 113 0.6× 55 0.3× 119 0.7× 14 2.7k
John A. Newitt United States 16 790 0.7× 50 0.2× 207 1.1× 162 0.9× 106 0.6× 25 1.5k
Joseph W. Arndt United States 20 993 0.9× 72 0.3× 65 0.3× 91 0.5× 159 0.9× 28 1.9k
A.S. Dore United Kingdom 26 3.2k 2.9× 194 0.8× 202 1.1× 233 1.3× 447 2.6× 37 3.6k
Hiroki Tsumoto Japan 25 1.4k 1.2× 120 0.5× 377 2.0× 163 0.9× 44 0.3× 69 2.0k
Till Maurer Germany 17 1.2k 1.0× 148 0.6× 101 0.5× 319 1.7× 126 0.7× 32 1.5k
David C. Fry United States 28 2.4k 2.1× 301 1.2× 494 2.6× 473 2.6× 294 1.7× 51 3.0k
Jennifer Reed Germany 22 1.6k 1.4× 175 0.7× 81 0.4× 151 0.8× 284 1.6× 44 2.4k
Kenneth H. Pearce United States 27 2.0k 1.8× 89 0.4× 185 1.0× 374 2.0× 146 0.8× 71 3.3k

Countries citing papers authored by Michael J. Bower

Since Specialization
Citations

This map shows the geographic impact of Michael J. Bower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Bower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Bower more than expected).

Fields of papers citing papers by Michael J. Bower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Bower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Bower. The network helps show where Michael J. Bower may publish in the future.

Co-authorship network of co-authors of Michael J. Bower

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Bower. A scholar is included among the top collaborators of Michael J. Bower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Bower. Michael J. Bower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hoots, Jennifer K., et al.. (2022). Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine. PLoS ONE. 17(10). e0275027–e0275027. 3 indexed citations
2.
Bower, Michael J., Alex M. Aronov, Thomas E. Cleveland, et al.. (2020). Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation. Journal of Chemical Information and Modeling. 60(4). 2091–2099. 2 indexed citations
3.
Yue, Eddy W., Brent Douty, Brian Wayland, et al.. (2009). Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model. Journal of Medicinal Chemistry. 52(23). 7364–7367. 187 indexed citations
4.
Bower, Michael J., Clare E. Aslan, & Marcel Rejmánek. (2009). Invasion Potential of Chinese Tallowtree (Triadica sebifera) in California's Central Valley. Invasive Plant Science and Management. 2(4). 386–395. 23 indexed citations
5.
Douty, Brent, Brian Wayland, J. Paul, et al.. (2007). Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorganic & Medicinal Chemistry Letters. 18(1). 66–71. 55 indexed citations
6.
Paul, J., Lucie Gonneville, Milton C. Hillman, et al.. (2006). Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics. Journal of Biological Chemistry. 281(43). 32784–32795. 61 indexed citations
7.
Yue, Eddy W., Brian Wayland, Brent Douty, et al.. (2006). Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure–activity relationships of a peptide scaffold. Bioorganic & Medicinal Chemistry. 14(17). 5833–5849. 44 indexed citations
8.
Wan, Zehong, Jeffrey C. Boehm, Michael J. Bower, et al.. (2003). N-Phenyl-N-purin-6-yl ureas: The design and synthesis of p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(6). 1191–1194. 23 indexed citations
9.
Zhao, Baoguang, Michael J. Bower, Patrick McDevitt, et al.. (2002). Structural Basis for Chk1 Inhibition by UCN-01. Journal of Biological Chemistry. 277(48). 46609–46615. 169 indexed citations
10.
Bower, Michael J., Patrick McDevitt, Haibo Zhao, et al.. (2002). Structural basis for Chk1 inhibition by UCN-01 and its analogs. Acta Crystallographica Section A Foundations of Crystallography. 58(s1). c224–c224. 1 indexed citations
11.
Boehm, Jeffrey C., Michael J. Bower, Timothy F. Gallagher, et al.. (2001). Phenoxypyrimidine inhibitors of p38α kinase. Bioorganic & Medicinal Chemistry Letters. 11(9). 1123–1126. 34 indexed citations
12.
Gum, Rebecca J., Megan M. McLaughlin, Sanjay Kumar, et al.. (1998). Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket. Journal of Biological Chemistry. 273(25). 15605–15610. 195 indexed citations
13.
Dunbrack, Roland L., Dietlind L. Gerloff, Michael J. Bower, et al.. (1997). Meeting review: the Second Meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, December 13–16, 1996. PubMed. 2(2). R27–R42. 44 indexed citations
14.
Bower, Michael J., Fred E. Cohen, & Roland L. Dunbrack. (1997). Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. Journal of Molecular Biology. 267(5). 1268–1282. 461 indexed citations
15.
Spellmeyer, David C., Alex K. Wong, Michael J. Bower, & Jeffrey M. Blaney. (1997). Conformational analysis using distance geometry methods. Journal of Molecular Graphics and Modelling. 15(1). 18–36. 68 indexed citations
16.
Bach, A., Charles J. Eyermann, John D. Gross, et al.. (1994). Structural Studies of a Family of High Affinity Ligands for GPIIb/IIIa. Journal of the American Chemical Society. 116(8). 3207–3219. 95 indexed citations
17.
Brooke, Gerald M., et al.. (1993). Remarkable orientational effects in the displacement of the fluorine from heptafluoro-isoquinoline and -quinoline towards sulfur nucleophiles. Further reactions with oxygen nucleophiles. Journal of the Chemical Society Perkin Transactions 1. 2201–2201. 14 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilena Manea Breakdown of academic impact, for papers by Shilpa Sambashivan Breakdown of academic impact, for papers by John A. Newitt Breakdown of academic impact, for papers by Joseph W. Arndt Breakdown of academic impact, for papers by A.S. Dore Breakdown of academic impact, for papers by Hiroki Tsumoto Breakdown of academic impact, for papers by Till Maurer Breakdown of academic impact, for papers by David C. Fry Breakdown of academic impact, for papers by Jennifer Reed Breakdown of academic impact, for papers by Kenneth H. Pearce
Rankless by CCL
2026